In addition, while mediators of innate inflammation positioned within the NF-κΒ pathway, such as tumor necrosis factor, promote lung carcinogenesis [7-11,29], our studies provide evidence that inflammatory mediators involved in other inflammatory signaling pathways, such as IL-5, do not affect lung tumor formation and progression. This evidence concerns the gene IL5 and medical procedure.